Clinical Trials Directory

Trials / Completed

CompletedNCT01422083

Glenohumeral Internal Rotation Deficit (GIRD)

Correlation Between Loss of Internal Rotation Range of Motion and Size of the Subacromial Space and the Influence of a Home Stretching Program.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University Ghent · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

A loss of mobility in the shoulder in direction of internal rotation is associated with shoulder tendon pathology. Cause-effect relationship between these two is still not clear. It is suspected that this loss of mobility reduces the size of the tunnel in which this shoulder tendon is lying, namely the subacromial space. Overhead athletes frequently show glenohumeral internal rotation deficit (GIRD) while being healthy and free of shoulder pain. This makes this population interesting to investigate. This study wants to look at shoulders of overhead athletes with GIRD and measure the size of the subacromial space. After this, the athletes will be instructed to perform a home stretching program and at the end the effect of this on mobility and the size of the subacromial space will be measured.60 athletes will be recruited and randomly allocated to the control group and the stretching group. Before they start stretching, subacromial space size will be measured by use of ultrasound. This is a safe and non-invasive measuring tool. Mobility will be measured by use of a digital inclinometer. This also is safe and non-invasive. Patients will be instructed a stretching exercise, which they will be performing at home once a day during 6 weeks. At the end all outcome measures will be reassessed.

Conditions

Interventions

TypeNameDescription
PROCEDUREhome stretching programA home stretching program (sleeper's stretch): 3 x 30 seconds, once a day for 6 weeks.

Timeline

Start date
2010-09-01
Primary completion
2015-04-01
Completion
2015-06-01
First posted
2011-08-23
Last updated
2021-11-19

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01422083. Inclusion in this directory is not an endorsement.